Skip to content
lifestyle.harcourthealth.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Krystal Biotech, Inc.
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
July 23, 2026
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 22, 2026
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
May 7, 2026
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
May 4, 2026
Krystal Biotech to Present at Upcoming Scientific Conferences
April 30, 2026
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
April 21, 2026
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
February 24, 2026
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
February 18, 2026
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
February 11, 2026
Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
February 11, 2026